# Accelerate research with a direct connection to patients Access Evidation’s highly engaged health community to effectively recruit for your trials, engage patients over time, and go to market faster. ## Trial Recruitment and Experience **Understand patients’ experiences and unmet needs** to reduce burden and increase retention through an ongoing connection to patients **Quickly test hypotheses** with digital measures and fast responses from an engaged health community **Accelerate enrollment** into your trials by recruiting from a well-characterized, engaged, and research-motivated community **Meet your diversity goals** with access to 97% of U.S. zip codes and social determinants of health data ## Generating Real-World Evidence **Quantify health and quality of life** outcomes with longitudinal data collected directly from patients, including validated ePROs and objective digital measures **Demonstrate value at every stage of treatment development** through a deeper understanding of the patient experience, unmet needs, and underserved groups **Differentiate treatment value and support stakeholder decisions** with evidence aligned to emerging drivers of market value **Publish peer-reviewed communications** to increase treatment consideration and shape clinical guidelines with data collected through prospective, longitudinal real-world studies ## Commercial Planning **Build more robust patient journeys** with longitudinal surveys, validated ePROs, and digital measures **Increase access** by uncovering patient journey barriers and opportunities to intervene outside of traditional care settings **Respond to questions faster** with access to our responsive, well-characterized community **Boost marketing effectiveness** with more nuanced segmentation based on real-world measures **Prioritize investment decisions** with a deeper understanding of what’s actually driving patient behavior and outcomes in everyday life ## Solutions we offer for life sciences companies: Trial Recruitment Patient Insights Patient Experience Datasets Real-World Studies Research & Engagement Platform ## Case Studies **Segmenting patients by real-world symptom control** Evidation partnered with a leading pharmaceutical company to understand the asthma patient journey and management experience. 14K individuals with asthma recruited from the Evidation Community Recruitment completed in 1 week **Identifying and addressing gaps in the patient experience** Myovant uncovered significant unmet needs among individuals with uterine fibroids (UF) in a direct-to-patient 4-month study with 350 women living with UF. 92% weekly survey completion 85% daily survey completion **Low-burden, objective assessment of symptoms and disease progression** Evidation partnered with a large pharmaceutical company to conduct a real-world study to create a more complete picture of multiple sclerosis (MS) patients’ experiences by combining data from wearable devices with medical claims and demographics data. 500+ individuals with MS recruited from the Evidation Community **Increasing treatment rates with co-created patient engagement** Evidation partnered with Sanofi to test and refine content and messaging for a Type 2 diabetes flu vaccine education program. 10K individuals recruited from the Evidation Community Up to 2x increase in vaccination rates for participants who engaged with customized diabetes campaign vs. those who engaged with generic messaging **Members who suffer from migraines receive personal health feedback** Evidation developed, and deployed, MigraineSmart, a symptom tracking health program that collects direct-from-participant data and provides educational content and personalized insights to participants, helping them better understand and manage their migraines. 3K+ individuals participated in the MigraineSmart program 48% said that tracking helps them better understand symptom patterns and migraine triggers **Exploring potential to reduce stroke risk with earlier detection of Afib** Evidation partnered with Johnson&Johnson to support a multi-year, observational study that sought to assess whether the Heartline™ Study app on iPhone, and the ECG app and irregular rhythm notification feature on Apple Watch, can reduce the likelihood of stroke and improve health outcomes with earlier detection of atrial fibrillation. 30K+ participants aged 65+ **Rapid enrollment of representative population in COVID-19 research** Evidation partnered with a leading pharmaceutical company to build a patient engagement program focused on COVID-19 that engages a representative population across the United States. 100K individuals enrolled into research program in 5 weeks 90%+ program engagement 1.5K of those participants recruited into real-world evidence study in 2 weeks **Measuring cognitive impairment with direct-from-patient real-world data** Evidation partnered with Eli Lilly to develop new endpoints and identify digital signals of cognitive impairment through the use of digital and wearable devices, mobile apps, and sleep sensors. 16TB of multimodal data collected over 12 weeks 1K+ features extracted from participant behaviorgrams **Developing more successful digital health programs with patient perspectives** Evidation partnered with Sanofi to get data-driven insights to prioritize program features and future development of a connected ecosystem for managing type 2 diabetes (T2D). 114 insulin-dependent adults with T2D recruited from the Evidation community Recruitment completed in 3 weeks **Demonstrating improved quality of life and activity levels in PNH patients** Evidation partnered with a leading pharmaceutical company to conduct a 32-week direct-to-participant study with paroxysmal nocturnal hemoglobinuria (PNH) patients to characterize patient experiences while using a C5 inhibitor. 30+ individuals diagnosed with PNH and taking a specific therapy >80% compliance with study activities ## Therapeutic experience ## Who we work with Evidation partners include top biopharma companies, as well as consumer health companies, technology companies, non-profit organizations, and government agencies.